| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RS domain binding | 8.02e-09 | 8 | 67 | 4 | GO:0050733 | |
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | 1.25e-06 | 7 | 67 | 3 | GO:0030628 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 2.39e-06 | 64 | 67 | 5 | GO:0036002 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 5.84e-06 | 11 | 67 | 3 | GO:0099122 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 6.72e-05 | 65 | 67 | 4 | GO:0070063 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain phosphoserine binding | 1.10e-04 | 5 | 67 | 2 | GO:1990269 | |
| GeneOntologyMolecularFunction | protein domain specific binding | SCAF1 U2AF1 LUC7L SRSF7 SCAF8 PHRF1 U2AF2 GRIK5 SRRM2 RBM39 SON | 1.46e-04 | 875 | 67 | 11 | GO:0019904 |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 3.03e-04 | 39 | 67 | 3 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 4.63e-04 | 45 | 67 | 3 | GO:0043175 | |
| GeneOntologyMolecularFunction | mRNA binding | 4.96e-04 | 694 | 67 | 9 | GO:0003729 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 7.16e-04 | 12 | 67 | 2 | GO:0050815 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.13e-03 | 61 | 67 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.42e-03 | 66 | 67 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.42e-03 | 66 | 67 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | C2H2 zinc finger domain binding | 1.46e-03 | 17 | 67 | 2 | GO:0070742 | |
| GeneOntologyBiologicalProcess | mRNA processing | ARL6IP4 SNRNP27 SRRM1 SCAF1 U2AF1 LUC7L ZRSR2P1 SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 RNPS1 SCAF8 CDK13 PHRF1 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A CWC25 SRRM2 THRAP3 RBM39 RSRC1 SCAF4 SON | 1.16e-29 | 551 | 67 | 30 | GO:0006397 |
| GeneOntologyBiologicalProcess | RNA splicing | ARL6IP4 SNRNP27 SRRM1 SCAF1 U2AF1 LUC7L ZRSR2P1 PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RNPS1 CDK13 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A CWC25 SRRM2 THRAP3 RBM39 RSRC1 SON | 2.24e-26 | 502 | 67 | 27 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | ARL6IP4 SNRNP27 SRRM1 SCAF1 U2AF1 LUC7L ZRSR2P1 SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 RNPS1 SCAF8 CDK13 PHRF1 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A CWC25 SRRM2 PLEKHN1 THRAP3 RBM39 RSRC1 SCAF4 SON | 1.93e-24 | 917 | 67 | 31 | GO:0016071 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | SNRNP27 SRRM1 U2AF1 LUC7L ZRSR2P1 SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 CDK13 ACIN1 U2AF2 PRPF38A CWC25 SRRM2 THRAP3 RBM39 RSRC1 SON | 1.00e-19 | 358 | 67 | 20 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | SNRNP27 SRRM1 U2AF1 LUC7L ZRSR2P1 SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 CDK13 ACIN1 U2AF2 PRPF38A CWC25 SRRM2 THRAP3 RBM39 RSRC1 SON | 1.00e-19 | 358 | 67 | 20 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | SNRNP27 SRRM1 U2AF1 LUC7L ZRSR2P1 SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 CDK13 ACIN1 U2AF2 PRPF38A CWC25 SRRM2 THRAP3 RBM39 RSRC1 SON | 1.25e-19 | 362 | 67 | 20 | GO:0000375 |
| GeneOntologyBiologicalProcess | RNA processing | ARL6IP4 SNRNP27 SRRM1 SCAF1 U2AF1 LUC7L ZRSR2P1 PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 RNPS1 SCAF8 CDK13 PHRF1 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A CWC25 SRRM2 THRAP3 RBM39 RSRC1 SCAF4 SON | 3.50e-18 | 1500 | 67 | 31 | GO:0006396 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.18e-11 | 129 | 67 | 10 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | SRRM1 SRSF3 SRSF6 SRSF7 AKAP17A RNPS1 ACIN1 U2AF2 THRAP3 RBM39 SON | 6.27e-11 | 207 | 67 | 11 | GO:0043484 |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 8.90e-11 | 158 | 67 | 10 | GO:0050684 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 2.88e-08 | 28 | 67 | 5 | GO:0048025 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 3.47e-08 | 29 | 67 | 5 | GO:0050686 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 6.87e-08 | 33 | 67 | 5 | GO:0033119 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | SRRM1 SRSF3 SRSF6 SRSF7 RNPS1 ACIN1 U2AF2 PLEKHN1 THRAP3 RBM39 SON | 1.73e-07 | 443 | 67 | 11 | GO:1903311 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.99e-06 | 115 | 67 | 6 | GO:1903312 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 5.82e-06 | 79 | 67 | 5 | GO:0000380 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 1.04e-05 | 2 | 67 | 2 | GO:2000805 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription | 1.04e-05 | 2 | 67 | 2 | GO:0120191 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 3.11e-05 | 3 | 67 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 3.11e-05 | 3 | 67 | 2 | GO:2000804 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription, poly(A)-coupled | 3.11e-05 | 3 | 67 | 2 | GO:0030846 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 6.21e-05 | 4 | 67 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 1.55e-04 | 6 | 67 | 2 | GO:0031554 | |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 3.04e-04 | 99 | 67 | 4 | GO:0000245 | |
| GeneOntologyBiologicalProcess | cellular response to leukemia inhibitory factor | 3.53e-04 | 103 | 67 | 4 | GO:1990830 | |
| GeneOntologyBiologicalProcess | response to leukemia inhibitory factor | 3.80e-04 | 105 | 67 | 4 | GO:1990823 | |
| GeneOntologyBiologicalProcess | mRNA splice site recognition | 6.46e-04 | 52 | 67 | 3 | GO:0006376 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 9.35e-04 | 59 | 67 | 3 | GO:0000381 | |
| GeneOntologyCellularComponent | nuclear speck | ARL6IP4 SRRM1 U2AF1 PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 RNPS1 CDK13 BCLAF1 ACIN1 U2AF2 SRSF11 TOPORS CWC25 SRRM2 THRAP3 RBM39 RSRC1 SON | 4.74e-22 | 431 | 69 | 23 | GO:0016607 |
| GeneOntologyCellularComponent | nuclear body | ARL6IP4 SRRM1 U2AF1 PPIG CENPT SRSF3 SRSF6 SRSF7 RNF6 AKAP17A INCENP LUC7L3 RBM27 RNPS1 CDK13 BCLAF1 ACIN1 U2AF2 SRSF11 TOPORS CWC25 SRRM2 THRAP3 RBM39 PHC1 RSRC1 SON | 1.95e-19 | 903 | 69 | 27 | GO:0016604 |
| GeneOntologyCellularComponent | spliceosomal complex | SRRM1 U2AF1 LUC7L ZRSR2P1 AKAP17A LUC7L3 U2AF2 PRPF38B PRPF38A CWC25 SRRM2 | 1.14e-10 | 215 | 69 | 11 | GO:0005681 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SNRNP27 SRRM1 U2AF1 LUC7L ZRSR2P1 AKAP17A LUC7L3 RNPS1 SCAF8 CDK13 BCLAF1 KDM2B ACIN1 U2AF2 PRPF38B PRPF38A CWC25 SRRM2 THRAP3 PHC1 | 1.06e-08 | 1377 | 69 | 20 | GO:0140513 |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 8.08e-07 | 97 | 69 | 6 | GO:0005684 | |
| GeneOntologyCellularComponent | U2AF complex | 1.19e-06 | 7 | 69 | 3 | GO:0089701 | |
| GeneOntologyCellularComponent | U2-type prespliceosome | 2.71e-05 | 18 | 69 | 3 | GO:0071004 | |
| GeneOntologyCellularComponent | prespliceosome | 2.71e-05 | 18 | 69 | 3 | GO:0071010 | |
| GeneOntologyCellularComponent | exon-exon junction complex | 4.39e-05 | 21 | 69 | 3 | GO:0035145 | |
| GeneOntologyCellularComponent | ASAP complex | 6.42e-05 | 4 | 69 | 2 | GO:0061574 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | SNRNP27 SRRM1 U2AF1 LUC7L ZRSR2P1 SRSF6 AKAP17A LUC7L3 U2AF2 PRPF38B PRPF38A CWC25 SRRM2 | 1.25e-04 | 1194 | 69 | 13 | GO:1990904 |
| GeneOntologyCellularComponent | precatalytic spliceosome | 7.57e-04 | 54 | 69 | 3 | GO:0071011 | |
| Domain | Nucleotide-bd_a/b_plait | U2AF1 ZRSR2P1 SRSF3 SRSF6 SRSF7 AKAP17A RBM27 RNPS1 PPRC1 SCAF8 ACIN1 U2AF2 SRSF11 RBM39 SCAF4 | 5.72e-15 | 258 | 63 | 15 | IPR012677 |
| Domain | RRM | U2AF1 ZRSR2P1 SRSF3 SRSF6 SRSF7 RBM27 RNPS1 PPRC1 SCAF8 ACIN1 U2AF2 SRSF11 RBM39 SCAF4 | 1.21e-14 | 217 | 63 | 14 | SM00360 |
| Domain | RRM_dom | U2AF1 ZRSR2P1 SRSF3 SRSF6 SRSF7 RBM27 RNPS1 PPRC1 SCAF8 ACIN1 U2AF2 SRSF11 RBM39 SCAF4 | 2.27e-14 | 227 | 63 | 14 | IPR000504 |
| Domain | RRM | U2AF1 ZRSR2P1 SRSF3 SRSF6 SRSF7 AKAP17A RBM27 RNPS1 PPRC1 SCAF8 U2AF2 SRSF11 RBM39 SCAF4 | 2.72e-14 | 230 | 63 | 14 | PS50102 |
| Domain | RRM_1 | U2AF1 ZRSR2P1 SRSF3 SRSF6 SRSF7 RBM27 RNPS1 PPRC1 SCAF8 U2AF2 SRSF11 RBM39 SCAF4 | 1.78e-13 | 208 | 63 | 13 | PF00076 |
| Domain | - | SRSF3 SRSF6 SRSF7 AKAP17A RBM27 RNPS1 PPRC1 SCAF8 ACIN1 U2AF2 SRSF11 RBM39 SCAF4 | 1.38e-12 | 244 | 63 | 13 | 3.30.70.330 |
| Domain | PRP38 | 1.12e-05 | 2 | 63 | 2 | IPR005037 | |
| Domain | PRP38 | 1.12e-05 | 2 | 63 | 2 | PF03371 | |
| Domain | THRAP3_BCLAF1 | 3.35e-05 | 3 | 63 | 2 | PF15440 | |
| Domain | THRAP3_BCLAF1 | 3.35e-05 | 3 | 63 | 2 | IPR029199 | |
| Domain | LUC7 | 3.35e-05 | 3 | 63 | 2 | PF03194 | |
| Domain | Luc7-rel | 3.35e-05 | 3 | 63 | 2 | IPR004882 | |
| Domain | PWI | 1.11e-04 | 5 | 63 | 2 | PF01480 | |
| Domain | U2AF_small | 1.11e-04 | 5 | 63 | 2 | IPR009145 | |
| Domain | - | 1.11e-04 | 5 | 63 | 2 | 1.20.1390.10 | |
| Domain | PWI_dom | 1.11e-04 | 5 | 63 | 2 | IPR002483 | |
| Domain | RNA_pol_II-bd | 2.33e-04 | 7 | 63 | 2 | IPR006903 | |
| Domain | CTD_bind | 2.33e-04 | 7 | 63 | 2 | PF04818 | |
| Domain | RPR | 3.09e-04 | 8 | 63 | 2 | SM00582 | |
| Domain | CID_dom | 3.09e-04 | 8 | 63 | 2 | IPR006569 | |
| Domain | CID | 3.09e-04 | 8 | 63 | 2 | PS51391 | |
| Domain | zf-CCCH | 6.03e-04 | 49 | 63 | 3 | PF00642 | |
| Domain | Znf_CCCH | 9.89e-04 | 58 | 63 | 3 | IPR000571 | |
| Domain | - | 2.26e-03 | 21 | 63 | 2 | 1.10.720.30 | |
| Domain | SAP | 2.48e-03 | 22 | 63 | 2 | PF02037 | |
| Domain | SAP | 2.71e-03 | 23 | 63 | 2 | SM00513 | |
| Domain | SAP | 3.20e-03 | 25 | 63 | 2 | PS50800 | |
| Domain | SAP_dom | 3.20e-03 | 25 | 63 | 2 | IPR003034 | |
| Domain | - | 3.45e-03 | 26 | 63 | 2 | 1.25.40.90 | |
| Domain | ENTH_VHS | 4.29e-03 | 29 | 63 | 2 | IPR008942 | |
| Pathway | REACTOME_MRNA_SPLICING | SNRNP27 SRRM1 U2AF1 PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38A CWC25 SRRM2 RBM39 | 2.29e-19 | 212 | 49 | 17 | M14033 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | SNRNP27 SRRM1 U2AF1 PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38A CWC25 SRRM2 RBM39 | 3.16e-17 | 283 | 49 | 17 | M13087 |
| Pathway | REACTOME_MRNA_SPLICING | SNRNP27 SRRM1 U2AF1 ZRSR2P1 SRSF3 SRSF7 LUC7L3 RNPS1 ACIN1 U2AF2 SRSF11 PRPF38A CWC25 SRRM2 RBM39 | 1.24e-16 | 201 | 49 | 15 | MM15411 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | SNRNP27 SRRM1 U2AF1 ZRSR2P1 SRSF3 SRSF7 LUC7L3 RNPS1 ACIN1 U2AF2 SRSF11 PRPF38A CWC25 SRRM2 RBM39 | 1.49e-14 | 277 | 49 | 15 | MM15414 |
| Pathway | WP_MRNA_PROCESSING | SRRM1 U2AF1 ZRSR2P1 SRSF3 SRSF6 SRSF7 AKAP17A RNPS1 SCAF8 BCLAF1 ACIN1 U2AF2 SRSF11 RSRC2 RBM39 SON | 1.17e-12 | 451 | 49 | 16 | MM15946 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 6.54e-11 | 67 | 49 | 8 | M27694 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | SNRNP27 SRRM1 U2AF1 PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38A CWC25 SRRM2 RBM39 | 1.38e-10 | 724 | 49 | 17 | M16843 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 4.18e-10 | 84 | 49 | 8 | M725 | |
| Pathway | KEGG_SPLICEOSOME | 4.45e-10 | 127 | 49 | 9 | M2044 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | SNRNP27 SRRM1 U2AF1 ZRSR2P1 SRSF3 SRSF7 LUC7L3 RNPS1 ACIN1 U2AF2 SRSF11 PRPF38A CWC25 SRRM2 RBM39 | 1.24e-09 | 612 | 49 | 15 | MM15547 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.67e-09 | 62 | 49 | 7 | MM15426 | |
| Pathway | WP_MRNA_PROCESSING | 1.08e-08 | 126 | 49 | 8 | M39406 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.71e-08 | 86 | 49 | 7 | MM15413 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 7.64e-04 | 12 | 49 | 2 | MM15105 | |
| Pathway | WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2 | 1.38e-03 | 16 | 49 | 2 | M39484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_OUTER_KINETOCHORE | 1.95e-03 | 19 | 49 | 2 | M47885 | |
| Pubmed | ARL6IP4 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RBM27 RNPS1 BCLAF1 ZRANB2 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A RSRC2 SRRM2 THRAP3 RBM39 RSRC1 SCAF4 SON | 6.03e-26 | 713 | 71 | 26 | 29802200 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ARL6IP4 SRRM1 U2AF1 PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 RNPS1 CDK13 BCLAF1 ZRANB2 FBRSL1 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38A RSRC2 SRRM2 THRAP3 RBM39 SCAF4 SON | 1.41e-24 | 807 | 71 | 26 | 22681889 |
| Pubmed | ARL6IP4 SNRNP27 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RBM27 RNPS1 BCLAF1 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A RSRC2 SRRM2 THRAP3 RBM39 RSRC1 SON | 3.11e-24 | 731 | 71 | 25 | 29298432 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | ARL6IP4 SNRNP27 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 CDK13 BCLAF1 ZRANB2 ACIN1 U2AF2 CACNA1H PRPF38A RSRC2 SRRM2 THRAP3 RBM39 RSRC1 SON | 2.44e-23 | 695 | 71 | 24 | 23602568 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ARL6IP4 SNRNP27 SRRM1 SCAF1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RBM27 RNPS1 CDK13 BCLAF1 PHRF1 CCAR1 KDM2B ACIN1 U2AF2 SRSF11 PRPF38A SRRM2 THRAP3 RBM39 CDCA7L RSRC1 SCAF4 SON | 3.96e-23 | 1294 | 71 | 29 | 30804502 |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | ARL6IP4 SRRM1 SCAF1 PPIG SRSF6 SRSF7 RNPS1 CDK13 BCLAF1 PHRF1 ZRANB2 ACIN1 PRPF38A SRRM2 THRAP3 PHC1 SON | 2.84e-21 | 259 | 71 | 17 | 30404004 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SNRNP27 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 BCLAF1 ZRANB2 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A RSRC2 SRRM2 THRAP3 RBM39 SCAF4 SON | 4.08e-20 | 1082 | 71 | 25 | 38697112 |
| Pubmed | ARL6IP4 SNRNP27 SRRM1 SCAF1 U2AF1 LUC7L PPIG SRSF7 AKAP17A LUC7L3 RBM27 RNPS1 CDK13 BCLAF1 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A RSRC2 CWC25 THRAP3 RSRC1 SCAF4 SON | 7.83e-19 | 1371 | 71 | 26 | 36244648 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | SRRM1 SCAF1 LUC7L PPIG EPM2A SRSF3 SRSF6 SRSF7 CDK13 BCLAF1 SRSF11 PRPF38B PRPF38A SRRM2 THRAP3 RBM39 SON | 8.05e-19 | 361 | 71 | 17 | 26167880 |
| Pubmed | SRRM1 U2AF1 LUC7L SRSF3 SRSF6 SRSF7 LUC7L3 RBM27 RNPS1 BCLAF1 PPP1R12A ZRANB2 CCAR1 ACIN1 U2AF2 SRSF11 SRRM2 THRAP3 RBM39 CDCA7L RSRC1 SON | 9.87e-19 | 847 | 71 | 22 | 35850772 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRM1 SCAF1 PPIG SRSF6 SRSF7 RNPS1 SCAF8 CDK13 BCLAF1 PHRF1 ZRANB2 CCAR1 KDM2B ACIN1 PRPF38B PRPF38A TOPORS SRRM2 THRAP3 SCAF4 SON | 2.91e-18 | 774 | 71 | 21 | 15302935 |
| Pubmed | ARL6IP4 SCAF1 LUC7L ZRSR2P1 PPIG AKAP17A LUC7L3 BCLAF1 ZRANB2 CCAR1 ACIN1 PRPF38B PRPF38A THRAP3 SCAF4 | 3.14e-18 | 251 | 71 | 15 | 31076518 | |
| Pubmed | ARL6IP4 U2AF1 LUC7L SRSF3 SRSF6 SRSF7 LUC7L3 U2AF2 SRSF11 PRPF38B PRPF38A SRRM2 RBM39 RSRC1 | 7.49e-18 | 206 | 71 | 14 | 34185411 | |
| Pubmed | SRRM1 U2AF1 ZRSR2P1 SRSF6 SRSF7 AKAP17A RBM27 RNPS1 PPRC1 SCAF8 ACIN1 U2AF2 SRSF11 RBM39 SCAF4 SON | 1.33e-17 | 347 | 71 | 16 | 16033648 | |
| Pubmed | ARL6IP4 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 CDK13 BCLAF1 ZRANB2 ACIN1 U2AF2 SRSF11 SRRM2 THRAP3 RBM39 | 4.50e-17 | 655 | 71 | 19 | 35819319 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ARL6IP4 SRRM1 SCAF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 RNPS1 SCAF8 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A SRRM2 THRAP3 RBM39 RSRC1 SON | 6.03e-17 | 1318 | 71 | 24 | 30463901 |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | SNRNP27 U2AF1 LUC7L PPIG SRSF3 SRSF6 RNPS1 CCAR1 ACIN1 U2AF2 PRPF38A SRRM2 RBM39 | 1.80e-16 | 197 | 71 | 13 | 22365833 |
| Pubmed | SNRNP27 SRRM1 U2AF1 LUC7L AKAP17A LUC7L3 RNPS1 U2AF2 PRPF38B RBM39 SON | 2.19e-16 | 104 | 71 | 11 | 31365120 | |
| Pubmed | ARL6IP4 MAGI1 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 RNF6 RNPS1 BCLAF1 PPP1R12A KDM2B ACIN1 U2AF2 SRSF11 PRPF38B RSRC2 TOPORS SRRM2 THRAP3 RBM39 | 2.38e-16 | 1247 | 71 | 23 | 27684187 | |
| Pubmed | SRRM1 U2AF1 SRSF3 SRSF6 SRSF7 RNPS1 CCAR1 ACIN1 U2AF2 SRRM2 RBM39 | 6.86e-16 | 115 | 71 | 11 | 17332742 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ARL6IP4 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF7 RNPS1 CDK13 BCLAF1 ZRANB2 CCAR1 ACIN1 U2AF2 SRRM2 THRAP3 RBM39 RSRC1 | 1.13e-15 | 665 | 71 | 18 | 30457570 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SRRM1 U2AF1 CENPT SRSF3 SRSF6 SRSF7 INCENP LUC7L3 RBM27 BCLAF1 CCAR1 ACIN1 U2AF2 SRSF11 CWC25 SRRM2 THRAP3 RBM39 SCAF4 SON | 2.88e-15 | 954 | 71 | 20 | 36373674 |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | SNRNP27 SRRM1 U2AF1 LUC7L PPIG SRSF3 AKAP17A LUC7L3 RNPS1 U2AF2 SRSF11 PRPF38B RBM39 | 1.03e-14 | 269 | 71 | 13 | 29511261 |
| Pubmed | A novel SR-related protein is required for the second step of Pre-mRNA splicing. | 5.33e-14 | 12 | 71 | 6 | 15798186 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MAGI1 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RNPS1 BCLAF1 PPP1R12A ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38B SRRM2 THRAP3 SON | 6.55e-14 | 1284 | 71 | 21 | 17353931 |
| Pubmed | SRRM1 U2AF1 SRSF3 SRSF6 SRSF7 RNPS1 CCAR1 ACIN1 U2AF2 SRRM2 THRAP3 SON | 7.52e-14 | 239 | 71 | 12 | 26641092 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KIAA1671 SRRM1 SCAF1 U2AF1 LUC7L SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 BCLAF1 ACIN1 U2AF2 SRSF11 SRRM2 THRAP3 RBM39 SCAF4 SON | 1.41e-13 | 1024 | 71 | 19 | 24711643 |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | ARL6IP4 SNRNP27 SCAF1 LUC7L PPIG INCENP LUC7L3 RNPS1 BCLAF1 ACIN1 PRPF38A THRAP3 SON | 1.41e-13 | 330 | 71 | 13 | 33301849 |
| Pubmed | SRRM1 PPIG SRSF3 LUC7L3 RNPS1 BCLAF1 PPP1R12A ACIN1 PRPF38B SRRM2 THRAP3 SON | 1.63e-13 | 255 | 71 | 12 | 15324660 | |
| Pubmed | SRSF3 SRSF6 SRSF7 RNPS1 BCLAF1 ZRANB2 CCAR1 ACIN1 SRRM2 THRAP3 RBM39 | 1.66e-13 | 188 | 71 | 11 | 29721183 | |
| Pubmed | ARL6IP4 KIAA1671 SRRM1 U2AF1 PPIG SRSF6 SRSF7 RNPS1 BCLAF1 PPP1R12A ACIN1 U2AF2 SRSF11 PRPF38A SRRM2 THRAP3 | 2.88e-13 | 660 | 71 | 16 | 32780723 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | KIAA1671 SRRM1 SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 BCLAF1 PPP1R12A ACIN1 SRRM2 THRAP3 SON | 4.42e-13 | 361 | 71 | 13 | 30344098 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | SCAF1 U2AF1 SRSF3 SRSF6 SRSF7 INCENP LUC7L3 RBM27 BCLAF1 ZRANB2 CCAR1 ACIN1 U2AF2 SRSF11 SRRM2 THRAP3 RBM39 SON | 9.55e-13 | 989 | 71 | 18 | 36424410 |
| Pubmed | SNRNP27 SRRM1 SCAF1 LUC7L SRSF6 SCAF8 U2AF2 SRSF11 PRPF38B PRPF38A SRRM2 RBM39 | 1.11e-12 | 300 | 71 | 12 | 28561026 | |
| Pubmed | SNRNP27 U2AF1 LUC7L SRSF3 SRSF6 SRSF7 RNPS1 CDK13 ZRANB2 U2AF2 SRSF11 PRPF38B PRPF38A SRRM3 THRAP3 PHC1 | 1.14e-12 | 723 | 71 | 16 | 34133714 | |
| Pubmed | 1.32e-12 | 109 | 71 | 9 | 12226669 | ||
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 2.01e-12 | 169 | 71 | 10 | 23084401 | |
| Pubmed | 5.18e-12 | 80 | 71 | 8 | 25662211 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | SRRM1 U2AF1 LUC7L SRSF6 SRSF7 LUC7L3 CDK13 BCLAF1 PPP1R12A CCAR1 U2AF2 SRRM2 THRAP3 RBM39 SCAF4 | 5.40e-12 | 670 | 71 | 15 | 22990118 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SRRM1 U2AF1 LUC7L SRSF3 SRSF6 SRSF7 LUC7L3 SCAF8 ACIN1 U2AF2 SRSF11 SRRM2 THRAP3 RBM39 | 1.16e-11 | 582 | 71 | 14 | 20467437 |
| Pubmed | 1.41e-11 | 11 | 71 | 5 | 9472028 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | SRRM1 U2AF1 LUC7L SRSF3 SRSF6 SRSF7 LUC7L3 BCLAF1 CCAR1 ACIN1 U2AF2 SRRM2 THRAP3 RBM39 | 1.94e-11 | 605 | 71 | 14 | 28977666 |
| Pubmed | ARL6IP4 SRRM1 LUC7L PPIG SRSF6 RNPS1 PPP1R12A ACIN1 U2AF2 PRPF38A RSRC2 SRRM2 THRAP3 | 2.09e-11 | 491 | 71 | 13 | 36273042 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 3.05e-11 | 154 | 71 | 9 | 16055720 | |
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 3.86e-11 | 60 | 71 | 7 | 29055695 | |
| Pubmed | LPIN3 SRRM1 LUC7L3 BCLAF1 PPP1R12A CCAR1 U2AF2 SRRM2 THRAP3 RBM39 | 5.06e-11 | 234 | 71 | 10 | 36243803 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | ARL6IP4 SRRM1 BCLAF1 ZRANB2 ACIN1 SRSF11 PRPF38A SRRM2 THRAP3 | 5.07e-11 | 163 | 71 | 9 | 22113938 |
| Pubmed | SRSF3 SRSF6 SRSF7 BCLAF1 CCAR1 ACIN1 U2AF2 THRAP3 RBM39 RSRC1 | 7.62e-11 | 244 | 71 | 10 | 29884807 | |
| Pubmed | SRRM1 SRSF3 SRSF6 SRSF7 LUC7L3 BCLAF1 U2AF2 SRRM2 THRAP3 RBM39 | 7.93e-11 | 245 | 71 | 10 | 21182205 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | SRRM1 LUC7L SRSF3 SRSF6 SRSF7 LUC7L3 RBM27 CDK13 BCLAF1 U2AF2 SRSF11 THRAP3 RBM39 SON | 8.67e-11 | 678 | 71 | 14 | 30209976 |
| Pubmed | 3.59e-10 | 203 | 71 | 9 | 35012549 | ||
| Pubmed | ARL6IP4 KIAA1671 SRRM1 SCAF1 AKAP17A RNPS1 PPP1R12A PHRF1 FBRSL1 U2AF2 ABHD8 RSRC2 TOPORS SRRM2 PLEKHN1 SON | 6.93e-10 | 1116 | 71 | 16 | 31753913 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | SRRM1 AKAP17A INCENP LUC7L3 CDK13 BCLAF1 U2AF2 SRSF11 RSRC2 SRRM2 RBM39 | 9.35e-10 | 420 | 71 | 11 | 28065597 |
| Pubmed | CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | 9.69e-10 | 94 | 71 | 7 | 37468549 | |
| Pubmed | Spatial mapping of splicing factor complexes involved in exon and intron definition. | 1.11e-09 | 8 | 71 | 4 | 18559666 | |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 1.13e-09 | 96 | 71 | 7 | 25948554 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 1.54e-09 | 162 | 71 | 8 | 31363146 | |
| Pubmed | 1.99e-09 | 9 | 71 | 4 | 19857271 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | U2AF1 SRSF3 SRSF6 SRSF7 RNPS1 BCLAF1 U2AF2 SRSF11 PRPF38A SRRM2 THRAP3 RBM39 SON | 2.01e-09 | 714 | 71 | 13 | 28302793 |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 2.26e-09 | 170 | 71 | 8 | 16159877 | |
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 2.42e-09 | 107 | 71 | 7 | 20508642 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ARL6IP4 SRRM1 U2AF1 LUC7L SRSF3 SRSF6 SRSF7 LUC7L3 SCAF8 CDK13 ZRANB2 U2AF2 SRRM2 THRAP3 RBM39 RSRC1 SON | 2.69e-09 | 1415 | 71 | 17 | 28515276 |
| Pubmed | 3.16e-09 | 260 | 71 | 9 | 36199071 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 3.55e-09 | 180 | 71 | 8 | 30110629 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | SRRM1 U2AF1 LUC7L SRSF6 LUC7L3 BCLAF1 ZRANB2 U2AF2 SRRM2 THRAP3 RBM39 | 4.27e-09 | 486 | 71 | 11 | 30940648 |
| Pubmed | KIAA1671 SCAF1 AKAP17A RBM27 SCAF8 CDK13 PPP1R12A PHRF1 ZRANB2 CCAR1 KDM2B PRPF38B PRPF38A RSRC2 RSRC1 SCAF4 SON | 6.23e-09 | 1497 | 71 | 17 | 31527615 | |
| Pubmed | SRRM1 U2AF1 CDK13 BCLAF1 ZRANB2 ACIN1 SRSF11 SRRM2 THRAP3 SCAF4 SON | 6.47e-09 | 506 | 71 | 11 | 30890647 | |
| Pubmed | ARL6IP4 SRRM1 CENPT INCENP RBM27 RNPS1 BCLAF1 PPP1R12A CCAR1 RSRC2 THRAP3 PHC1 | 7.06e-09 | 645 | 71 | 12 | 25281560 | |
| Pubmed | Nucleocytoplasmic shuttling of heterodimeric splicing factor U2AF. | 8.15e-09 | 3 | 71 | 3 | 11118443 | |
| Pubmed | SRRM1 SRSF6 BCLAF1 PPP1R12A ACIN1 U2AF2 SRSF11 SRRM2 THRAP3 SON | 8.75e-09 | 399 | 71 | 10 | 35987950 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 9.44e-09 | 130 | 71 | 7 | 35545047 | |
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 1.12e-08 | 13 | 71 | 4 | 20516191 | |
| Pubmed | SRRM1 U2AF1 SRSF3 SRSF6 SRSF7 INCENP PHRF1 ZRANB2 U2AF2 SRSF11 | 1.59e-08 | 425 | 71 | 10 | 24999758 | |
| Pubmed | 1.76e-08 | 317 | 71 | 9 | 30997501 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | SRSF6 SRSF7 LUC7L3 RNPS1 BCLAF1 ZRANB2 U2AF2 SRSF11 RSRC2 CWC25 THRAP3 RBM39 | 1.86e-08 | 704 | 71 | 12 | 32994395 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SCAF1 U2AF1 SRSF3 SRSF6 SRSF7 INCENP LUC7L3 RNPS1 BCLAF1 ZRANB2 CCAR1 ACIN1 U2AF2 SRRM2 THRAP3 RBM39 | 2.21e-08 | 1425 | 71 | 16 | 30948266 |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 2.25e-08 | 85 | 71 | 6 | 16051665 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KIAA1671 U2AF1 SRSF3 SRSF6 SRSF7 INCENP RBM27 RNPS1 BCLAF1 PPP1R12A ACIN1 U2AF2 TOPORS THRAP3 RBM39 | 2.96e-08 | 1257 | 71 | 15 | 36526897 |
| Pubmed | 3.26e-08 | 4 | 71 | 3 | 10809668 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KIAA1671 MAGI1 LUC7L SRSF3 LUC7L3 SCAF8 CDK13 PPP1R12A FBRSL1 CCAR1 U2AF2 SRSF11 PRPF38B CACNA1H THRAP3 RBM39 | 4.06e-08 | 1489 | 71 | 16 | 28611215 |
| Pubmed | PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ. | 4.41e-08 | 47 | 71 | 5 | 29934401 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | SRRM1 SRSF7 RBM27 BCLAF1 PPP1R12A ACIN1 SRRM2 THRAP3 RBM39 SON | 4.69e-08 | 477 | 71 | 10 | 31300519 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | SRRM1 U2AF1 LUC7L AKAP17A LUC7L3 CDK13 BCLAF1 PPP1R12A U2AF2 SRRM2 THRAP3 RBM39 SON | 5.77e-08 | 949 | 71 | 13 | 36574265 |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 5.85e-08 | 258 | 71 | 8 | 37794589 | |
| Pubmed | Splicing factor TRA2B is required for neural progenitor survival. | 6.04e-08 | 19 | 71 | 4 | 23818142 | |
| Pubmed | Recruitment of the human TREX complex to mRNA during splicing. | 7.54e-08 | 20 | 71 | 4 | 15998806 | |
| Pubmed | 9.28e-08 | 274 | 71 | 8 | 34244482 | ||
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 1.18e-07 | 57 | 71 | 5 | 14559993 | |
| Pubmed | 1.18e-07 | 57 | 71 | 5 | 21555454 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.19e-07 | 283 | 71 | 8 | 30585729 | |
| Pubmed | 1.29e-07 | 286 | 71 | 8 | 32041737 | ||
| Pubmed | 1.36e-07 | 403 | 71 | 9 | 35253629 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.61e-07 | 411 | 71 | 9 | 35182466 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 2.35e-07 | 430 | 71 | 9 | 38172120 | |
| Pubmed | 2.54e-07 | 210 | 71 | 7 | 16565220 | ||
| Pubmed | Functional properties of p54, a novel SR protein active in constitutive and alternative splicing. | 2.84e-07 | 7 | 71 | 3 | 8816452 | |
| Pubmed | 2.84e-07 | 7 | 71 | 3 | 9237760 | ||
| Pubmed | ARL6IP4 SRSF7 RBM27 CDK13 BCLAF1 ZRANB2 CCAR1 PRPF38B RSRC2 SRRM2 THRAP3 RBM39 SCAF4 | 3.23e-07 | 1103 | 71 | 13 | 34189442 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | SRRM1 SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 BCLAF1 PPP1R12A ACIN1 SRRM2 THRAP3 SCAF4 | 3.42e-07 | 922 | 71 | 12 | 27609421 |
| Pubmed | 3.47e-07 | 220 | 71 | 7 | 24550385 | ||
| Interaction | SRPK2 interactions | ARL6IP4 SNRNP27 SRRM1 SCAF1 U2AF1 LUC7L PPIG EPM2A SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 RNPS1 CDK13 BCLAF1 ZRANB2 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A RSRC2 SRRM2 THRAP3 RBM39 RSRC1 SCAF4 SON | 2.30e-27 | 717 | 67 | 31 | int:SRPK2 |
| Interaction | JMJD6 interactions | ARL6IP4 SCAF1 U2AF1 LUC7L ZRSR2P1 PPIG AKAP17A LUC7L3 RBM27 SCAF8 PHRF1 U2AF2 SRSF11 PRPF38B PRPF38A RSRC2 RBM39 RSRC1 SCAF4 SON | 2.09e-24 | 205 | 67 | 20 | int:JMJD6 |
| Interaction | CLK2 interactions | SNRNP27 SRRM1 U2AF1 LUC7L SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 BCLAF1 ACIN1 U2AF2 SRSF11 PRPF38A SRRM2 THRAP3 RBM39 SON | 1.54e-21 | 195 | 67 | 18 | int:CLK2 |
| Interaction | LUC7L interactions | SRRM1 LUC7L PPIG SRSF6 SRSF7 LUC7L3 RBM27 RNPS1 BCLAF1 H1-7 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38B SRRM2 THRAP3 RSRC1 SCAF4 | 2.30e-21 | 242 | 67 | 19 | int:LUC7L |
| Interaction | DHX8 interactions | SRRM1 SCAF1 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 RNPS1 CDK13 BCLAF1 PHRF1 ZRANB2 SRSF11 PRPF38A RSRC2 CWC25 SRRM2 THRAP3 RBM39 SON | 2.72e-21 | 292 | 67 | 20 | int:DHX8 |
| Interaction | SRSF11 interactions | ARL6IP4 SRRM1 LUC7L PPIG SRSF3 SRSF6 SRSF7 RNPS1 BCLAF1 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38B SRRM2 THRAP3 RBM39 SON | 3.22e-21 | 203 | 67 | 18 | int:SRSF11 |
| Interaction | SRPK1 interactions | ARL6IP4 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RBM27 RNPS1 BCLAF1 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38A RSRC2 SRRM2 THRAP3 RBM39 RSRC1 SON | 4.84e-21 | 477 | 67 | 23 | int:SRPK1 |
| Interaction | ZC3H18 interactions | ARL6IP4 SNRNP27 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 RNPS1 BCLAF1 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A RSRC2 TOPORS SRRM2 THRAP3 RBM39 RSRC1 SON | 9.27e-20 | 877 | 67 | 27 | int:ZC3H18 |
| Interaction | DDX23 interactions | SRRM1 SCAF1 U2AF1 PPIG SRSF6 SRSF7 AKAP17A LUC7L3 RNPS1 CDK13 BCLAF1 PHRF1 ZRANB2 ACIN1 U2AF2 SRSF11 RSRC2 CWC25 SRRM2 THRAP3 RBM39 RSRC1 | 1.22e-19 | 480 | 67 | 22 | int:DDX23 |
| Interaction | SNRNP70 interactions | ARL6IP4 SRRM1 SCAF1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RBM27 RNPS1 BCLAF1 PPP1R12A ZRANB2 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A RSRC2 SRRM2 THRAP3 RBM39 RSRC1 SCAF4 SON | 1.25e-19 | 984 | 67 | 28 | int:SNRNP70 |
| Interaction | SRRM4 interactions | ARL6IP4 SRRM1 U2AF1 LUC7L ZRSR2P1 AKAP17A RNPS1 SRSF11 PRPF38A RBM39 RSRC1 | 1.85e-19 | 37 | 67 | 11 | int:SRRM4 |
| Interaction | SRSF7 interactions | SRRM1 SCAF1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 PPRC1 BCLAF1 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38A SRRM2 THRAP3 RBM39 SON | 2.08e-19 | 425 | 67 | 21 | int:SRSF7 |
| Interaction | SRSF6 interactions | SRRM1 SCAF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 AKAP17A RNPS1 CDK13 BCLAF1 PHRF1 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A TOPORS SRRM2 THRAP3 RBM39 SON | 3.34e-19 | 503 | 67 | 22 | int:SRSF6 |
| Interaction | SRPK3 interactions | SRRM1 U2AF1 LUC7L SRSF3 SRSF6 LUC7L3 CDK13 ACIN1 U2AF2 SRSF11 PRPF38A SRRM2 THRAP3 RBM39 SCAF4 SON | 1.52e-18 | 190 | 67 | 16 | int:SRPK3 |
| Interaction | SRSF4 interactions | SRRM1 SCAF1 PPIG SRSF3 SRSF6 SRSF7 AKAP17A RNPS1 CDK13 ACIN1 U2AF2 SRSF11 PRPF38A TOPORS SRRM2 THRAP3 RBM39 SON | 3.76e-18 | 300 | 67 | 18 | int:SRSF4 |
| Interaction | RNPS1 interactions | SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RNPS1 ACIN1 U2AF2 SRSF11 PRPF38A TOPORS SRRM2 THRAP3 RBM39 SCAF4 SON | 4.53e-18 | 425 | 67 | 20 | int:RNPS1 |
| Interaction | SAP18 interactions | SRRM1 SCAF1 U2AF1 PPIG SRSF3 SRSF6 SRSF7 RNPS1 PHRF1 ACIN1 U2AF2 SRSF11 PRPF38B TOPORS SRRM2 THRAP3 RBM39 SON | 5.04e-18 | 305 | 67 | 18 | int:SAP18 |
| Interaction | CLK3 interactions | SRRM1 LUC7L PPIG SRSF3 SRSF6 SRSF7 RNPS1 BCLAF1 ACIN1 U2AF2 SRSF11 PRPF38B TOPORS SRRM2 THRAP3 RBM39 | 1.61e-17 | 220 | 67 | 16 | int:CLK3 |
| Interaction | PNN interactions | SRRM1 SCAF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 AKAP17A RNPS1 BCLAF1 ACIN1 U2AF2 SRSF11 TOPORS SRRM2 THRAP3 RBM39 | 1.06e-16 | 302 | 67 | 17 | int:PNN |
| Interaction | ACIN1 interactions | SRRM1 U2AF1 LUC7L SRSF6 SRSF7 RNPS1 PHRF1 ZRANB2 ACIN1 U2AF2 SRSF11 SRRM2 THRAP3 RBM39 SCAF4 SON | 2.33e-15 | 301 | 67 | 16 | int:ACIN1 |
| Interaction | SNRNP40 interactions | SNRNP27 SRRM1 SCAF1 CENPT SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 SCAF8 BCLAF1 PHRF1 CCAR1 ACIN1 U2AF2 SRRM2 RBM39 RSRC1 SCAF4 SON | 1.07e-14 | 637 | 67 | 20 | int:SNRNP40 |
| Interaction | CLK1 interactions | SRRM1 PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 BCLAF1 U2AF2 SRSF11 PRPF38A SRRM2 THRAP3 RBM39 | 1.24e-14 | 219 | 67 | 14 | int:CLK1 |
| Interaction | SRSF1 interactions | SRRM1 SCAF1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RNPS1 CDK13 U2AF2 SRSF11 SRRM2 THRAP3 RBM39 RSRC1 SON | 1.93e-14 | 570 | 67 | 19 | int:SRSF1 |
| Interaction | FOLR1 interactions | ARL6IP4 U2AF1 LUC7L SRSF3 SRSF6 SRSF7 LUC7L3 U2AF2 SRSF11 PRPF38B PRPF38A SRRM2 RBM39 RSRC1 | 2.04e-14 | 227 | 67 | 14 | int:FOLR1 |
| Interaction | SNIP1 interactions | ARL6IP4 SRRM1 SCAF1 PPIG SRSF6 SRSF7 RNPS1 CDK13 BCLAF1 PHRF1 ZRANB2 ACIN1 PRPF38A TOPORS SRRM2 THRAP3 SON | 2.21e-14 | 417 | 67 | 17 | int:SNIP1 |
| Interaction | LUC7L2 interactions | SNRNP27 U2AF1 LUC7L SRSF6 SRSF7 LUC7L3 RNPS1 BCLAF1 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38A SRRM2 THRAP3 RBM39 | 2.80e-14 | 353 | 67 | 16 | int:LUC7L2 |
| Interaction | RNF113A interactions | ARL6IP4 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 CDK13 BCLAF1 ZRANB2 CCAR1 ACIN1 U2AF2 SRSF11 SRRM2 THRAP3 RBM39 | 5.05e-14 | 692 | 67 | 20 | int:RNF113A |
| Interaction | PRPF40A interactions | SNRNP27 SRRM1 U2AF1 LUC7L PPIG SRSF7 RNPS1 CDK13 PPP1R12A ACIN1 U2AF2 SRSF11 PRPF38A SRRM2 RBM39 SCAF4 SON | 6.61e-14 | 446 | 67 | 17 | int:PRPF40A |
| Interaction | MECP2 interactions | SNRNP27 SRRM1 U2AF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 BCLAF1 ZRANB2 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A RSRC2 SRRM2 THRAP3 RBM39 SCAF4 SON | 1.34e-13 | 1287 | 67 | 25 | int:MECP2 |
| Interaction | NKAPD1 interactions | ARL6IP4 SRRM1 SCAF1 PPIG RNPS1 BCLAF1 ACIN1 U2AF2 PRPF38A SRRM2 THRAP3 RBM39 | 1.83e-13 | 161 | 67 | 12 | int:NKAPD1 |
| Interaction | U2AF2 interactions | SRRM1 SCAF1 U2AF1 LUC7L ZRSR2P1 SRSF3 SRSF6 SRSF7 RNPS1 BCLAF1 ZRANB2 CCAR1 ACIN1 U2AF2 SRSF11 SRRM2 THRAP3 RBM39 SON | 2.07e-13 | 651 | 67 | 19 | int:U2AF2 |
| Interaction | SNRPA interactions | ARL6IP4 SRRM1 LUC7L PPIG LUC7L3 RNPS1 BCLAF1 CCAR1 ACIN1 U2AF2 SRSF11 SRRM2 THRAP3 RBM39 RSRC1 SCAF4 SON | 2.32e-13 | 482 | 67 | 17 | int:SNRPA |
| Interaction | DOT1L interactions | SRRM1 U2AF1 LUC7L SRSF3 SRSF6 SRSF7 LUC7L3 RBM27 RNPS1 PPP1R12A ZRANB2 CCAR1 ACIN1 SRSF11 SRRM2 THRAP3 RBM39 CDCA7L RSRC1 SON | 8.73e-13 | 807 | 67 | 20 | int:DOT1L |
| Interaction | NR2C2 interactions | ARL6IP4 SRRM1 SCAF1 LUC7L KLF12 PPIG SRSF3 SRSF6 SRSF7 AKAP17A LUC7L3 RBM27 RNPS1 SCAF8 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38B PRPF38A SRRM2 THRAP3 RBM39 RSRC1 SON | 9.21e-13 | 1403 | 67 | 25 | int:NR2C2 |
| Interaction | KIF23 interactions | ARL6IP4 SRRM1 U2AF1 PPIG SRSF3 SRSF6 SRSF7 AKAP17A INCENP LUC7L3 RNPS1 BCLAF1 PPP1R12A ZRANB2 CCAR1 ACIN1 U2AF2 PRPF38B PRPF38A SRRM2 THRAP3 SON | 9.50e-13 | 1031 | 67 | 22 | int:KIF23 |
| Interaction | RAD18 interactions | ARL6IP4 SCAF1 LUC7L ZRSR2P1 PPIG AKAP17A LUC7L3 BCLAF1 ZRANB2 CCAR1 ACIN1 PRPF38B PRPF38A SRRM2 THRAP3 SCAF4 | 1.47e-12 | 457 | 67 | 16 | int:RAD18 |
| Interaction | SRRM2 interactions | SRRM1 U2AF1 LUC7L SRSF3 SRSF6 SRSF7 AKAP17A RNPS1 ZRANB2 ACIN1 U2AF2 SRSF11 SRRM2 SRRM3 RBM39 SON | 1.73e-12 | 462 | 67 | 16 | int:SRRM2 |
| Interaction | ZRANB2 interactions | ARL6IP4 U2AF1 LUC7L SRSF7 AKAP17A LUC7L3 ZRANB2 ACIN1 U2AF2 SRSF11 SRRM2 SRRM3 | 2.30e-12 | 199 | 67 | 12 | int:ZRANB2 |
| Interaction | BARD1 interactions | SRRM1 U2AF1 LUC7L SRSF6 SRSF7 LUC7L3 CDK13 BCLAF1 CCAR1 U2AF2 SRRM2 THRAP3 RBM39 SCAF4 | 2.54e-12 | 323 | 67 | 14 | int:BARD1 |
| Interaction | SF3B1 interactions | SRRM1 U2AF1 SRSF3 SRSF6 RNPS1 BCLAF1 H1-7 CCAR1 ACIN1 U2AF2 TOPORS SRRM2 THRAP3 RBM39 PHC1 RSRC1 SON | 3.50e-12 | 571 | 67 | 17 | int:SF3B1 |
| Interaction | SF3A2 interactions | SRRM1 U2AF1 SRSF3 SRSF6 SRSF7 RNPS1 BCLAF1 CCAR1 ACIN1 U2AF2 SRRM2 THRAP3 RBM39 | 5.14e-12 | 273 | 67 | 13 | int:SF3A2 |
| Interaction | SNRPB interactions | ARL6IP4 SRRM1 PPIG SRSF7 LUC7L3 RNPS1 BCLAF1 CCAR1 ACIN1 U2AF2 SRRM2 THRAP3 RBM39 RSRC1 SCAF4 SON | 9.41e-12 | 517 | 67 | 16 | int:SNRPB |
| Interaction | ATXN1 interactions | ARL6IP4 SRRM1 U2AF1 LUC7L KLF12 PPIG EPM2A SRSF3 SRSF7 RNPS1 CDK13 BCLAF1 ZRANB2 CCAR1 ACIN1 U2AF2 SRRM2 PLEKHN1 THRAP3 RBM39 RSRC1 | 1.00e-11 | 1039 | 67 | 21 | int:ATXN1 |
| Interaction | SNRPC interactions | ARL6IP4 SRRM1 LUC7L SRSF7 LUC7L3 RNPS1 PPRC1 BCLAF1 ACIN1 PRPF38A SRRM2 THRAP3 RBM39 SCAF4 SON | 1.18e-11 | 440 | 67 | 15 | int:SNRPC |
| Interaction | CPSF6 interactions | ARL6IP4 SRRM1 PPIG SRSF6 SRSF7 AKAP17A RNPS1 BCLAF1 CCAR1 ACIN1 U2AF2 SRRM2 THRAP3 RBM39 SCAF4 SON | 1.22e-11 | 526 | 67 | 16 | int:CPSF6 |
| Interaction | PPIG interactions | LUC7L PPIG SRSF3 SRSF6 SRSF7 RNPS1 SRSF11 PRPF38A THRAP3 RBM39 | 1.26e-11 | 127 | 67 | 10 | int:PPIG |
| Interaction | MYCN interactions | ARL6IP4 SNRNP27 SRRM1 SCAF1 LUC7L PPIG SRSF3 SRSF6 SRSF7 RNPS1 CDK13 BCLAF1 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38B CWC25 SRRM2 THRAP3 RBM39 RSRC1 SON | 3.54e-11 | 1373 | 67 | 23 | int:MYCN |
| Interaction | SMC5 interactions | SRRM1 U2AF1 CENPT SRSF3 SRSF6 SRSF7 INCENP LUC7L3 RBM27 BCLAF1 CCAR1 ACIN1 U2AF2 SRSF11 CWC25 SRRM2 THRAP3 RBM39 SCAF4 SON | 4.27e-11 | 1000 | 67 | 20 | int:SMC5 |
| Interaction | PRP4K interactions | LUC7L SRSF3 SRSF6 SRSF7 RNPS1 BCLAF1 ZRANB2 ACIN1 SRSF11 PRPF38A SRRM2 THRAP3 RBM39 | 5.31e-11 | 329 | 67 | 13 | int:PRP4K |
| Interaction | OBSL1 interactions | SRRM1 SCAF1 U2AF1 SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 BCLAF1 ZRANB2 ACIN1 U2AF2 SRSF11 PRPF38B SRRM2 THRAP3 RBM39 SCAF4 SON | 6.09e-11 | 902 | 67 | 19 | int:OBSL1 |
| Interaction | S100A9 interactions | U2AF1 SRSF3 SRSF7 LUC7L3 RNPS1 ACIN1 U2AF2 SRSF11 TOPORS THRAP3 RBM39 SON | 6.58e-11 | 265 | 67 | 12 | int:S100A9 |
| Interaction | CIT interactions | KIAA1671 MAGI1 SNRNP27 SRRM1 SCAF1 LUC7L SRSF3 SRSF6 SRSF7 INCENP LUC7L3 RBM27 RNPS1 BCLAF1 PPP1R12A ACIN1 U2AF2 PRPF38B PRPF38A SRRM2 THRAP3 RBM39 SON | 1.06e-10 | 1450 | 67 | 23 | int:CIT |
| Interaction | RBBP6 interactions | LUC7L PPIG SRSF3 SRSF6 SRSF7 RNPS1 BCLAF1 ACIN1 SRRM2 THRAP3 SON | 1.26e-10 | 216 | 67 | 11 | int:RBBP6 |
| Interaction | SRSF3 interactions | SRRM1 SCAF1 U2AF1 PPIG SRSF3 SRSF6 SRSF7 RNPS1 CDK13 U2AF2 SRSF11 PRPF38A SRRM2 THRAP3 RBM39 | 1.30e-10 | 522 | 67 | 15 | int:SRSF3 |
| Interaction | NUP43 interactions | ARL6IP4 SRRM1 SCAF1 CENPT SRSF3 SRSF7 INCENP LUC7L3 RNPS1 BCLAF1 PPP1R12A PHRF1 ACIN1 SRRM2 RBM39 SON | 1.57e-10 | 625 | 67 | 16 | int:NUP43 |
| Interaction | CSNK2A1 interactions | ARL6IP4 LPIN3 SRRM1 LUC7L AKAP17A RNPS1 BCLAF1 PHRF1 ZRANB2 FBRSL1 KDM2B ACIN1 SRSF11 PRPF38A SRRM2 THRAP3 RBM39 PHC1 RSRC1 | 1.64e-10 | 956 | 67 | 19 | int:CSNK2A1 |
| Interaction | ZBTB2 interactions | ARL6IP4 SNRNP27 SCAF1 LUC7L PPIG INCENP LUC7L3 RNPS1 BCLAF1 PPP1R12A ACIN1 PRPF38A THRAP3 SON | 2.08e-10 | 450 | 67 | 14 | int:ZBTB2 |
| Interaction | ZC3H14 interactions | ARL6IP4 SRRM1 LUC7L SRSF3 SRSF6 SRSF7 RNPS1 SRSF11 THRAP3 RBM39 | 2.16e-10 | 169 | 67 | 10 | int:ZC3H14 |
| Interaction | U2AF1 interactions | U2AF1 SRSF3 SRSF7 RNPS1 ZRANB2 ACIN1 U2AF2 PRPF38A SRRM2 RBM39 SON | 3.71e-10 | 239 | 67 | 11 | int:U2AF1 |
| Interaction | ECT2 interactions | ARL6IP4 KIAA1671 SRRM1 SRSF3 SRSF6 SRSF7 INCENP LUC7L3 RNPS1 BCLAF1 PPP1R12A ACIN1 U2AF2 PRPF38B PRPF38A SRRM2 THRAP3 SON | 3.96e-10 | 887 | 67 | 18 | int:ECT2 |
| Interaction | SRSF5 interactions | SRRM1 SCAF1 U2AF1 PPIG CENPT SRSF3 SRSF6 SRSF7 AKAP17A CDK13 U2AF2 PRPF38A SRRM2 SON | 4.10e-10 | 474 | 67 | 14 | int:SRSF5 |
| Interaction | IFI6 interactions | 5.09e-10 | 54 | 67 | 7 | int:IFI6 | |
| Interaction | NKAP interactions | 5.22e-10 | 132 | 67 | 9 | int:NKAP | |
| Interaction | UBE2O interactions | ARL6IP4 SRRM1 LUC7L PPIG SRSF6 AKAP17A RNPS1 CDK13 PPP1R12A H1-7 ACIN1 U2AF2 PRPF38A RSRC2 SRRM2 THRAP3 RBM39 | 5.51e-10 | 790 | 67 | 17 | int:UBE2O |
| Interaction | NUPR1 interactions | ARL6IP4 KIAA1671 SRRM1 U2AF1 PPIG SRSF6 SRSF7 RNPS1 BCLAF1 PPP1R12A ACIN1 U2AF2 SRSF11 PRPF38A SRRM2 THRAP3 | 5.72e-10 | 683 | 67 | 16 | int:NUPR1 |
| Interaction | RBM39 interactions | ARL6IP4 SRRM1 U2AF1 PPIG SRSF3 SRSF6 SRSF7 RNPS1 BCLAF1 CCAR1 ACIN1 U2AF2 SRSF11 PRPF38A SRRM2 THRAP3 RBM39 RSRC1 SON | 6.96e-10 | 1042 | 67 | 19 | int:RBM39 |
| Interaction | TOP1 interactions | ARL6IP4 SRRM1 SCAF1 RNPS1 BCLAF1 ZRANB2 CCAR1 ACIN1 U2AF2 SRSF11 TOPORS SRRM2 THRAP3 RBM39 SCAF4 SON | 7.52e-10 | 696 | 67 | 16 | int:TOP1 |
| Interaction | EIF4A3 interactions | SRRM1 SRSF3 SRSF6 SRSF7 AKAP17A RNPS1 ACIN1 U2AF2 PRPF38A SRRM2 THRAP3 RBM39 CDCA7L SON | 8.00e-10 | 499 | 67 | 14 | int:EIF4A3 |
| Interaction | TRA2A interactions | SRRM1 LUC7L PPIG SRSF3 SRSF6 SRSF7 RNPS1 U2AF2 SRSF11 SRRM2 THRAP3 RBM39 | 8.15e-10 | 330 | 67 | 12 | int:TRA2A |
| Interaction | LINC02910 interactions | 9.38e-10 | 95 | 67 | 8 | int:LINC02910 | |
| Interaction | TADA2A interactions | SRRM1 LUC7L KLF12 SRSF3 RNF6 LUC7L3 RNPS1 SRRM2 RBM39 CDCA7L | 1.02e-09 | 198 | 67 | 10 | int:TADA2A |
| Interaction | LUZP4 interactions | 1.31e-09 | 99 | 67 | 8 | int:LUZP4 | |
| Interaction | SRRM1 interactions | SRRM1 LUC7L SRSF3 SRSF6 SRSF7 RNPS1 BCLAF1 ACIN1 U2AF2 SRSF11 SRRM2 RBM39 | 1.49e-09 | 348 | 67 | 12 | int:SRRM1 |
| Interaction | SON interactions | 1.64e-09 | 208 | 67 | 10 | int:SON | |
| Interaction | THRAP3 interactions | LUC7L PPIG SRSF3 SRSF6 SRSF7 RNPS1 BCLAF1 PHRF1 ACIN1 U2AF2 SRSF11 THRAP3 RBM39 | 2.03e-09 | 443 | 67 | 13 | int:THRAP3 |
| Interaction | PPIE interactions | SRRM1 LUC7L SRSF3 SRSF6 SRSF7 RNPS1 ACIN1 U2AF2 SRSF11 SRRM2 RBM39 | 2.13e-09 | 282 | 67 | 11 | int:PPIE |
| Interaction | NCBP3 interactions | 2.31e-09 | 156 | 67 | 9 | int:NCBP3 | |
| Interaction | PRPF3 interactions | SNRNP27 SRRM1 SRSF7 RNPS1 CDK13 U2AF2 RCSD1 SRRM2 THRAP3 RBM39 SON | 2.96e-09 | 291 | 67 | 11 | int:PRPF3 |
| Interaction | BMI1 interactions | SRRM1 U2AF1 SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 SCAF8 BCLAF1 KDM2B ACIN1 THRAP3 PHC1 RSRC1 SON | 3.19e-09 | 659 | 67 | 15 | int:BMI1 |
| Interaction | SF3A1 interactions | SNRNP27 SRRM1 U2AF1 SRSF7 RNPS1 BCLAF1 CCAR1 ACIN1 U2AF2 SRRM2 THRAP3 RBM39 SON | 4.23e-09 | 471 | 67 | 13 | int:SF3A1 |
| Interaction | SNRPF interactions | SRRM1 LUC7L PPIG LUC7L3 BCLAF1 ACIN1 U2AF2 SRRM2 THRAP3 RBM39 RSRC1 SCAF4 | 4.64e-09 | 385 | 67 | 12 | int:SNRPF |
| Interaction | CD2BP2 interactions | SNRNP27 SRRM1 SRSF6 BCLAF1 SRSF11 PRPF38B SRRM2 THRAP3 RBM39 RSRC1 | 4.70e-09 | 232 | 67 | 10 | int:CD2BP2 |
| Interaction | ZCCHC10 interactions | SRRM1 U2AF1 PPIG AKAP17A SRSF11 PRPF38A TOPORS SRRM2 RBM39 SON | 5.54e-09 | 236 | 67 | 10 | int:ZCCHC10 |
| Interaction | BRD3 interactions | ARL6IP4 SRRM1 SCAF1 CENPT AKAP17A RNPS1 ACIN1 U2AF2 ABHD8 RSRC2 TOPORS SRRM2 SON | 7.48e-09 | 494 | 67 | 13 | int:BRD3 |
| Interaction | RBM25 interactions | SRRM1 U2AF1 LUC7L SRSF3 SRSF7 RNPS1 PPP1R12A SRSF11 PRPF38A SRRM2 RBM39 | 8.74e-09 | 323 | 67 | 11 | int:RBM25 |
| Interaction | SREK1 interactions | 9.37e-09 | 183 | 67 | 9 | int:SREK1 | |
| Interaction | CSNK2A2 interactions | ARL6IP4 LPIN3 SRRM1 LUC7L AKAP17A RNPS1 BCLAF1 PHRF1 FBRSL1 KDM2B SRRM2 THRAP3 RBM39 PHC1 RSRC1 | 1.01e-08 | 718 | 67 | 15 | int:CSNK2A2 |
| Interaction | PRC1 interactions | KIAA1671 SRRM1 SRSF3 SRSF6 SRSF7 INCENP LUC7L3 RNPS1 BCLAF1 PPP1R12A ACIN1 U2AF2 PRPF38B PRPF38A SRRM2 THRAP3 SON | 1.26e-08 | 973 | 67 | 17 | int:PRC1 |
| Interaction | YWHAG interactions | KIAA1671 LPIN3 MAGI1 SRRM1 LUC7L PPIG SRSF3 AKAP17A LUC7L3 RNPS1 BCLAF1 PPP1R12A ACIN1 SRSF11 PRPF38B SRRM2 THRAP3 RSRC1 SON | 1.35e-08 | 1248 | 67 | 19 | int:YWHAG |
| Interaction | CHERP interactions | SNRNP27 U2AF1 LUC7L SRSF6 SRSF7 RNPS1 CCAR1 U2AF2 PRPF38A RBM39 | 1.50e-08 | 262 | 67 | 10 | int:CHERP |
| Interaction | MAGOH interactions | 1.61e-08 | 264 | 67 | 10 | int:MAGOH | |
| Interaction | NKTR interactions | 1.96e-08 | 90 | 67 | 7 | int:NKTR | |
| Interaction | SUZ12 interactions | U2AF1 LUC7L SRSF3 SRSF6 SRSF7 LUC7L3 RNPS1 BCLAF1 ACIN1 U2AF2 THRAP3 RBM39 CDCA7L SON | 2.06e-08 | 644 | 67 | 14 | int:SUZ12 |
| Interaction | CFAP20 interactions | 2.11e-08 | 91 | 67 | 7 | int:CFAP20 | |
| Interaction | UQCR11 interactions | 2.18e-08 | 53 | 67 | 6 | int:UQCR11 | |
| Interaction | CASC3 interactions | 2.29e-08 | 142 | 67 | 8 | int:CASC3 | |
| Interaction | JPH3 interactions | 2.74e-08 | 55 | 67 | 6 | int:JPH3 | |
| Interaction | SRSF8 interactions | 3.55e-08 | 98 | 67 | 7 | int:SRSF8 | |
| Interaction | IK interactions | 3.79e-08 | 215 | 67 | 9 | int:IK | |
| Interaction | ZC3H11A interactions | 3.79e-08 | 215 | 67 | 9 | int:ZC3H11A | |
| Cytoband | 12q24.31 | 2.67e-04 | 80 | 71 | 3 | 12q24.31 | |
| Cytoband | 1p31 | 4.86e-04 | 21 | 71 | 2 | 1p31 | |
| Cytoband | 16p13.3 | 5.72e-04 | 244 | 71 | 4 | 16p13.3 | |
| GeneFamily | RNA binding motif containing | U2AF1 ZRSR2P1 SRSF3 SRSF6 SRSF7 RBM27 RNPS1 PPRC1 SCAF8 U2AF2 SRSF11 RBM39 SCAF4 | 5.30e-16 | 213 | 40 | 13 | 725 |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 1.00e-08 | 12 | 40 | 4 | 737 | |
| GeneFamily | ASAP complex|SIN3 histone deacetylase complex | 1.43e-05 | 3 | 40 | 2 | 1236 | |
| GeneFamily | Zinc fingers CCCH-type | 2.71e-03 | 35 | 40 | 2 | 73 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | ARL6IP4 SNRNP27 SRRM1 U2AF1 PPIG SRSF3 SRSF6 SRSF7 LUC7L3 ZRANB2 OSER1 ACIN1 U2AF2 SRSF11 PRPF38B RSRC2 SRRM2 THRAP3 RBM39 SON | 1.44e-11 | 1144 | 71 | 20 | MM3843 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | KIAA1671 LUC7L LUC7L3 SCAF8 CCAR1 ACIN1 SRSF11 PRPF38B SRRM2 RBM39 | 1.81e-07 | 417 | 71 | 10 | M39224 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SRRM1 SCAF1 U2AF1 SRSF3 SRSF6 LUC7L3 RNPS1 PHRF1 ZRANB2 U2AF2 SRSF11 PRPF38A RSRC2 THRAP3 SON | 2.82e-07 | 1129 | 71 | 15 | M42508 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SRRM1 SCAF1 U2AF1 SRSF3 SRSF6 LUC7L3 RNPS1 PHRF1 ZRANB2 U2AF2 SRSF11 PRPF38A RSRC2 THRAP3 SON | 3.89e-07 | 1158 | 71 | 15 | MM1338 |
| Coexpression | GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP | 9.08e-07 | 192 | 71 | 7 | M7558 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 3.70e-06 | 338 | 71 | 8 | M17094 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 5.29e-06 | 474 | 71 | 9 | M40991 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 6.23e-06 | 363 | 71 | 8 | M41103 | |
| Coexpression | GSE27786_BCELL_VS_NEUTROPHIL_UP | 1.74e-05 | 200 | 71 | 6 | M4813 | |
| Coexpression | XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN | 1.79e-05 | 19 | 71 | 3 | M11536 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 1.89e-05 | 203 | 71 | 6 | MM3795 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 2.19e-05 | 432 | 71 | 8 | M41149 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 2.48e-05 | 318 | 71 | 7 | M41707 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KLF12 PPIG SRSF7 RBM27 SCAF8 CDK13 BCLAF1 PPP1R12A PRPF38B RCSD1 RSRC2 THRAP3 RBM39 SON | 3.99e-05 | 1492 | 71 | 14 | M40023 |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP | 5.05e-05 | 242 | 71 | 6 | M904 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | 5.91e-05 | 644 | 71 | 9 | M41717 | |
| Coexpression | BENPORATH_CYCLING_GENES | 6.20e-05 | 648 | 71 | 9 | M8156 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 6.81e-05 | 656 | 71 | 9 | M18979 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | LUC7L KLF12 RNF6 AKAP17A IER3 OSER1 SRSF11 RSRC2 TOPORS RBM39 | 7.13e-05 | 822 | 71 | 10 | M6782 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 7.98e-05 | 519 | 71 | 8 | M3395 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 8.91e-05 | 166 | 71 | 5 | M8129 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | 9.62e-05 | 272 | 71 | 6 | M15123 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | 9.68e-05 | 687 | 71 | 9 | M41022 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 9.72e-05 | 534 | 71 | 8 | MM1054 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 1.09e-04 | 543 | 71 | 8 | MM997 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 1.12e-04 | 404 | 71 | 7 | M19488 | |
| Coexpression | TABULA_MURIS_SENIS_SKIN_BULGE_KERATINOCYTE_AGEING | ARL6IP4 SNRNP27 SRRM1 U2AF1 PPIG IER3 ACIN1 RSRC2 SRRM2 RBM39 | 1.72e-04 | 915 | 71 | 10 | MM3828 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CLASSICAL_MONOCYTE_AGEING | 1.91e-04 | 441 | 71 | 7 | MM3765 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 2.08e-04 | 199 | 71 | 5 | M9501 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 2.08e-04 | 199 | 71 | 5 | M6060 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 2.13e-04 | 200 | 71 | 5 | M8997 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN | 2.13e-04 | 200 | 71 | 5 | M9925 | |
| Coexpression | LEE_DIFFERENTIATING_T_LYMPHOCYTE | 2.18e-04 | 201 | 71 | 5 | M2200 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.44e-04 | 206 | 71 | 5 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.55e-04 | 208 | 71 | 5 | MM581 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 2.79e-04 | 212 | 71 | 5 | MM3816 | |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 3.52e-04 | 223 | 71 | 5 | M17621 | |
| Coexpression | CAFFAREL_RESPONSE_TO_THC_8HR_5_DN | 4.69e-04 | 12 | 71 | 2 | M2260 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.24e-09 | 105 | 71 | 8 | gudmap_developingGonad_e18.5_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SRRM1 KLF12 SRSF3 LUC7L3 BCLAF1 ACIN1 ZFTA SRSF11 PRPF38B RSRC2 TOPORS THRAP3 RBM39 | 2.18e-06 | 801 | 71 | 13 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.93e-06 | 186 | 71 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.69e-06 | 124 | 71 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SRRM1 PPIG CENPT USP51 LUC7L3 PPP1R12A CCAR1 SRSF11 PRPF38B PRPF38A SON | 7.20e-06 | 629 | 71 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | USP51 INCENP RBM27 BCLAF1 ZRANB2 ACIN1 RSRC2 TOPORS THRAP3 PHC1 | 1.05e-05 | 532 | 71 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SRRM1 KLF12 SRSF3 LUC7L3 BCLAF1 ACIN1 ZFTA SRSF11 RSRC2 TOPORS THRAP3 RBM39 | 1.10e-05 | 790 | 71 | 12 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SRRM1 KLF12 SRSF3 LUC7L3 BCLAF1 ACIN1 ZFTA SRSF11 RSRC2 TOPORS THRAP3 RBM39 | 1.23e-05 | 799 | 71 | 12 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500 | 1.35e-05 | 91 | 71 | 5 | gudmap_developingGonad_e14.5_ epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_500 | 1.35e-05 | 91 | 71 | 5 | gudmap_developingGonad_e16.5_epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | LPIN3 MAGI1 USP51 INCENP RBM27 BCLAF1 CCAR1 SRSF11 PRPF38B RTBDN RSRC2 SRRM3 CDCA7L | 1.98e-05 | 983 | 71 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.38e-05 | 271 | 71 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 3.73e-05 | 492 | 71 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SRRM1 PPIG INCENP LUC7L3 RBM27 BCLAF1 CCAR1 SRSF11 PRPF38B RSRC2 TOPORS THRAP3 PHC1 RSRC1 | 6.06e-05 | 1257 | 71 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 6.20e-05 | 406 | 71 | 8 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | SRRM1 KLF12 SRSF3 LUC7L3 BCLAF1 ACIN1 ZFTA SRSF11 PRPF38B THRAP3 RBM39 | 6.37e-05 | 797 | 71 | 11 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 6.98e-05 | 413 | 71 | 8 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SRRM1 SRSF3 LUC7L3 BCLAF1 ACIN1 SRSF11 PRPF38B RSRC2 TOPORS THRAP3 RBM39 | 7.04e-05 | 806 | 71 | 11 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.29e-05 | 136 | 71 | 5 | gudmap_developingGonad_P2_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.47e-04 | 150 | 71 | 5 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.59e-04 | 595 | 71 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.85e-04 | 249 | 71 | 6 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.35e-04 | 493 | 71 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SRRM1 PPIG INCENP LUC7L3 RBM27 BCLAF1 CCAR1 SRSF11 PRPF38B RSRC2 TOPORS THRAP3 PHC1 RSRC1 | 2.91e-04 | 1459 | 71 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.16e-04 | 275 | 71 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.55e-04 | 524 | 71 | 8 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | SCAF1 BCLAF1 ACIN1 ZFTA CACNA1H RSRC2 TOPORS THRAP3 RBM39 SON | 3.78e-04 | 819 | 71 | 10 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.79e-04 | 184 | 71 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.23e-04 | 47 | 71 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K3 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | LPIN3 SRRM1 LUC7L LUC7L3 FGFBP3 KDM2B CACNA1H GRIK5 ABHD8 SRRM2 CDCA7L PHC1 | 8.04e-04 | 1245 | 71 | 12 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 9.64e-04 | 469 | 71 | 7 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.06e-03 | 231 | 71 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SRRM1 PPIG LUC7L3 RBM27 SRSF11 PRPF38B RSRC2 SRRM2 RBM39 SON | 4.72e-13 | 188 | 71 | 10 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.32e-11 | 200 | 71 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 9.45e-10 | 196 | 71 | 8 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 9.84e-10 | 197 | 71 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 1.02e-09 | 198 | 71 | 8 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.07e-09 | 199 | 71 | 8 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-08 | 187 | 71 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.01e-08 | 198 | 71 | 7 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.01e-08 | 198 | 71 | 7 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-08 | 198 | 71 | 7 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 3.01e-08 | 198 | 71 | 7 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.12e-08 | 199 | 71 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.16e-07 | 191 | 71 | 6 | 6bc9c7c86040f3ebce08c350e625e345581d4550 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 6.35e-07 | 192 | 71 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.55e-07 | 193 | 71 | 6 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 6.55e-07 | 193 | 71 | 6 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 6.75e-07 | 194 | 71 | 6 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.75e-07 | 194 | 71 | 6 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 7.60e-07 | 198 | 71 | 6 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | PBMC|World / Compartment, Disease Groups and Clusters | 7.60e-07 | 198 | 71 | 6 | 84f5b43dad0c57556171dbc0b799735654582ecf | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.06e-07 | 200 | 71 | 6 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 8.06e-07 | 200 | 71 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-06 | 166 | 71 | 5 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-05 | 191 | 71 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 193 | 71 | 5 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 194 | 71 | 5 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | 10x3'2.3|World / cell types per 3 fetal stages;per 3',per 5' | 1.46e-05 | 194 | 71 | 5 | fc7ed8350ffe1475b8934dfbb107b51991876b0b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 194 | 71 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | lymphoid-T_cell-unlabelled(multiplets)|World / Lineage, cell class and subclass | 1.54e-05 | 196 | 71 | 5 | 78b006922307c154622d71fcbc79ae5eed3f4b23 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.58e-05 | 197 | 71 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 1.58e-05 | 197 | 71 | 5 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.58e-05 | 197 | 71 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-05 | 197 | 71 | 5 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.61e-05 | 198 | 71 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.61e-05 | 198 | 71 | 5 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.61e-05 | 198 | 71 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-05 | 198 | 71 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (2)_MNPs-(2)_Dendritic_Cells|(2)_MNPs / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.61e-05 | 198 | 71 | 5 | 4c1f155298b7d0afddfeb2744b369a1ffd823916 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.65e-05 | 199 | 71 | 5 | dd94e42b62af7cbd69c472681d3c758552694ae2 | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 1.65e-05 | 199 | 71 | 5 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.69e-05 | 200 | 71 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.63e-05 | 141 | 71 | 4 | c7043f3b024bb16bbc89e33075f5b6ced5cb9185 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.97e-05 | 147 | 71 | 4 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-04 | 155 | 71 | 4 | 9d53caee196b5c2bbc90c4f54f693b64d4086065 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 178 | 71 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 182 | 71 | 4 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 183 | 71 | 4 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.12e-04 | 184 | 71 | 4 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.26e-04 | 187 | 71 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.31e-04 | 188 | 71 | 4 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.35e-04 | 189 | 71 | 4 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 2.35e-04 | 189 | 71 | 4 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.45e-04 | 191 | 71 | 4 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.50e-04 | 192 | 71 | 4 | 48d557071bad80edd3ec6e5ad8dcd97037da9553 | |
| ToppCell | facs-Thymus-Flowthrough-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 192 | 71 | 4 | 7a0ef1702d6538e5611cfdc633d8558f9523845c | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 192 | 71 | 4 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 2.50e-04 | 192 | 71 | 4 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 192 | 71 | 4 | 05043fb75319b64f5ed7aee6a232309dcae891b8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-04 | 193 | 71 | 4 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-04 | 193 | 71 | 4 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 2.55e-04 | 193 | 71 | 4 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.55e-04 | 193 | 71 | 4 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Control-B_naive-13|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.55e-04 | 193 | 71 | 4 | 32e53a6473a682cf14b20a399c3686f658298b93 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.60e-04 | 194 | 71 | 4 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.60e-04 | 194 | 71 | 4 | 5022c85ad3b137dae4b9ff11f9c23bb3bf4c0f5a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 194 | 71 | 4 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.60e-04 | 194 | 71 | 4 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.65e-04 | 195 | 71 | 4 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.65e-04 | 195 | 71 | 4 | dc84a910b6f6eb9994cd683aa4fd813a82198e5f | |
| ToppCell | 3'|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.70e-04 | 196 | 71 | 4 | 44007f0c14e0f0703f7ee715b8eababb4d80a8b5 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 2.75e-04 | 197 | 71 | 4 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.81e-04 | 198 | 71 | 4 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-04 | 198 | 71 | 4 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | mLN-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 2.81e-04 | 198 | 71 | 4 | 404ec46bd39b6f4d02a03ef38c30850bbbd8b608 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-04 | 199 | 71 | 4 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 2.86e-04 | 199 | 71 | 4 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 2.86e-04 | 199 | 71 | 4 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.92e-04 | 200 | 71 | 4 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.92e-04 | 200 | 71 | 4 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.92e-04 | 200 | 71 | 4 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.51e-04 | 86 | 71 | 3 | 2df674969383d93509ea9e201452cfda702fae40 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.51e-04 | 86 | 71 | 3 | 8ead39a100fa5aedf93a2206edd9828538f990a5 | |
| Computational | RNA splicing. | 7.83e-06 | 65 | 46 | 5 | MODULE_183 | |
| Computational | Neighborhood of DDX5 | 1.45e-04 | 63 | 46 | 4 | GNF2_DDX5 | |
| Drug | AC1NRA5C | U2AF1 SRSF3 SRSF6 SRSF7 AKAP17A INCENP RNPS1 CDK13 ZRANB2 U2AF2 SRRM2 | 6.50e-12 | 174 | 71 | 11 | CID005287709 |
| Disease | Ependymoma | 1.50e-04 | 8 | 69 | 2 | C0014474 | |
| Disease | syndrome (implicated_via_orthology) | 8.05e-04 | 18 | 69 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | renal system measurement | 9.96e-04 | 20 | 69 | 2 | EFO_0004742 | |
| Disease | infant body height | 1.32e-03 | 23 | 69 | 2 | EFO_0006785 | |
| Disease | glucose measurement | 1.97e-03 | 380 | 69 | 5 | EFO_0004468 | |
| Disease | breast carcinoma | 2.55e-03 | 1019 | 69 | 8 | EFO_0000305 | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 2.72e-03 | 33 | 69 | 2 | DOID:4467 (is_marker_for) | |
| Disease | neutrophil percentage of leukocytes | 3.03e-03 | 610 | 69 | 6 | EFO_0007990 | |
| Disease | coenzyme Q10 measurement | 3.23e-03 | 36 | 69 | 2 | EFO_0007836 | |
| Disease | aortic stenosis, aortic valve calcification | 4.37e-03 | 42 | 69 | 2 | EFO_0000266, EFO_0005239 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WSPTRRRSRSPIRRR | 436 | Q13523 | |
| RRSRSPIRRRSRSPL | 441 | Q13523 | |
| PIRRRSRSPLRRSRS | 446 | Q13523 | |
| SRSPLRRSRSPRRRS | 451 | Q13523 | |
| LRRRSRSRGGRRRRS | 481 | Q13523 | |
| RSRGGRRRRSRSKVK | 486 | Q13523 | |
| PRKGERRSSRVRQAR | 221 | Q9UKV3 | |
| ASGRPRRPRRRASRA | 176 | B3EWF7 | |
| RPSRRSRAQRDRGRR | 6 | Q9HCM7 | |
| SRDRRSRSLGRRSRS | 281 | Q9NXE8 | |
| RRRSRERSPQRKRSR | 326 | Q8IX12 | |
| RTREAEPRRRARSKS | 81 | C9J069 | |
| TRGSIKRRPPSRRFR | 161 | Q6JBY9 | |
| RRPRRDRRSSSGRSK | 196 | Q14004 | |
| SRSRRRSGRAKRFVS | 201 | Q8TE58 | |
| GRRRRARRPKRTIHI | 146 | Q96I13 | |
| LSRSRSRSRGRSKDR | 176 | Q9P2N5 | |
| RKRSRSKERRRSRSR | 71 | Q14498 | |
| FRRRLSRATRKASRR | 331 | P47900 | |
| SKPRARNRGRTRERA | 166 | Q8TAT2 | |
| TASTGRRKRRRRRKP | 136 | Q9BQK8 | |
| RPSASRGHRKRSRRV | 51 | P46695 | |
| ERRRERSPTRRRDGS | 1381 | Q96QZ7 | |
| RRDGSPSRRRRSLER | 1391 | Q96QZ7 | |
| PERRAKSTDRRRARS | 1421 | Q96QZ7 | |
| KSTDRRRARSPERRR | 1426 | Q96QZ7 | |
| LSRRSGSRTRDRRRS | 256 | Q9NQ29 | |
| LRKRIHRPRRRTTRR | 11 | Q8NCT3 | |
| KRSRRRAPISHSLRR | 1651 | Q9BY89 | |
| PIRRRLSRRKSRSSQ | 81 | Q9NQS7 | |
| RPRRQRSKAKSRRSS | 1041 | Q9P1Y6 | |
| RSRDRRRSKSRDRKS | 346 | O95232 | |
| RRSRSRRSSIGLRVA | 131 | Q96GN5 | |
| KANARARRTRRARPR | 181 | Q75WM6 | |
| RRLQKRSSRHPRRSR | 2511 | P16112 | |
| TPPGRSRSKDRRRRR | 611 | Q13427 | |
| RTTAGARRRRTRCRK | 601 | Q8NHM5 | |
| RGRDPRRLRTSRSTE | 36 | Q5T8R8 | |
| RRGRSRSRSPKRRSV | 106 | Q9NYF8 | |
| CSPSSLGLRRRRRRT | 61 | Q8WZB0 | |
| RTPRRPRSARAGARR | 26 | Q96BT3 | |
| SRKRSRSRSRSRGRG | 6 | Q66PJ3 | |
| RSRSRSRGRGSEKRK | 11 | Q66PJ3 | |
| LLRGPRRRRSSKRAE | 76 | Q5VTJ3 | |
| RRQRRSESPDSRKRR | 301 | Q9Y4X4 | |
| RKTSRSRRRRRPGGP | 856 | Q16478 | |
| KRLRRLERRRRSTFP | 1576 | O95180 | |
| SRSASRSPKRRRSRS | 436 | O95104 | |
| RSPKRRRSRSGSRSR | 441 | O95104 | |
| SRSRSPRKRRSRSRS | 406 | Q9UPN6 | |
| PRKRRSRSRSGSRKR | 411 | Q9UPN6 | |
| SRSRSPSPRRRSDRR | 1501 | Q5VV67 | |
| RALRAGRSRRLTRVR | 191 | Q8NCU7 | |
| RRGREAPSRRSRSPR | 196 | Q9BSG5 | |
| RSRSRERKKSRSRSR | 136 | Q7L4I2 | |
| RSRSRERKKSRSRSR | 146 | Q7L4I2 | |
| RSRSRERKKSRSRSR | 156 | Q7L4I2 | |
| RSRSRTRSRSRDRKK | 191 | Q7L4I2 | |
| SRSSASAPRRRGRRR | 396 | A6NNA2 | |
| RRRSRSYSPIRKRRR | 551 | A6NNA2 | |
| SPVRRRSRSPGRRRH | 281 | Q15287 | |
| RRRTELRRSGSSRSP | 396 | Q494U1 | |
| RGRRSESSSPRRERK | 196 | Q9UQ35 | |
| GRSRSRTPARRGRSR | 571 | Q9UQ35 | |
| RGRSRSRTPARRRSR | 581 | Q9UQ35 | |
| RRRSRSRTPARRGRS | 601 | Q9UQ35 | |
| RRGRSRSRTPARRRS | 611 | Q9UQ35 | |
| RSRTPARRRSRTRSP | 616 | Q9UQ35 | |
| RTRSPVRRRSRSRSP | 626 | Q9UQ35 | |
| VRRRSRSRSPARRSG | 631 | Q9UQ35 | |
| RSRSPARRSGRSRSR | 636 | Q9UQ35 | |
| ARRSGRSRSRTPARR | 641 | Q9UQ35 | |
| RSRSRTPARRGRSRS | 646 | Q9UQ35 | |
| GRSRSRTPARRGRSR | 656 | Q9UQ35 | |
| RGRSRSRTPARRSGR | 666 | Q9UQ35 | |
| RRSGRSRSRTPARRG | 676 | Q9UQ35 | |
| SRSRTPARRGRSRSR | 681 | Q9UQ35 | |
| RSRSRTPRRGRSRSR | 691 | Q9UQ35 | |
| TPRRGRSRSRSLVRR | 696 | Q9UQ35 | |
| KPRGLQRSRSRSRRE | 1766 | Q9UQ35 | |
| SRTSSRRRRGRSRTP | 1831 | Q9UQ35 | |
| RRRRGRSRTPPTSRK | 1836 | Q9UQ35 | |
| RSRTPPTSRKRSRSR | 1841 | Q9UQ35 | |
| RRSRSRTPPVTRRRS | 1921 | Q9UQ35 | |
| TRRRSRSRTPTTRRR | 1931 | Q9UQ35 | |
| RRSRSRTPPVTRRRS | 1956 | Q9UQ35 | |
| TRRRSRSRTSPITRR | 1966 | Q9UQ35 | |
| RSRTSPITRRRSRSR | 1971 | Q9UQ35 | |
| RSRSRTSPVTRRRSR | 1981 | Q9UQ35 | |
| RRRSRSRTSPVTRRR | 1991 | Q9UQ35 | |
| RRSRSRTPPAIRRRS | 2016 | Q9UQ35 | |
| RSRTPLLPRKRSRSR | 2031 | Q9UQ35 | |
| RSRSRSPLAIRRRSR | 2041 | Q9UQ35 | |
| RRRSRSRTPRTARGK | 2051 | Q9UQ35 | |
| MGRSRSRSPRRERRR | 1 | Q8WVK2 | |
| TTRRSVRRRGRTRVF | 336 | Q9Y252 | |
| KSRSRSRSRSKGRSR | 221 | Q13247 | |
| TRKSSRGAVRTQRRR | 66 | Q9NX31 | |
| RGAVRTQRRRRSKSP | 71 | Q9NX31 | |
| RRERSRERRGSASRK | 656 | Q02040 | |
| RRRSRPGSRPQTRRS | 151 | Q70EK9 | |
| RSRSRSLSRSRKRRL | 31 | Q9Y2W1 | |
| RRGRSRSRSPKRRSP | 121 | Q9Y2W1 | |
| PRGRRGARRRATRTF | 121 | Q9NRA0 | |
| PRRRSPRRRSFSRSR | 111 | P84103 | |
| SRSRRRSKSPRRRRS | 281 | Q05519 | |
| RERRRRRSRSGTRSP | 341 | Q05519 | |
| DRRRGGSRRSRSREK | 591 | Q9H7N4 | |
| RSREKRRRRRRSASP | 601 | Q9H7N4 | |
| SSREKRERSRSPRRR | 161 | Q8IYB3 | |
| RERSRSPRRRKSRSP | 166 | Q8IYB3 | |
| SPRRRSSPVRRERKR | 181 | Q8IYB3 | |
| SRSPVRRRRRSSASL | 341 | Q8IYB3 | |
| RQKETSPRGRRRRSP | 536 | Q8IYB3 | |
| ERRRSRSPRRSLSPR | 256 | Q5VTL8 | |
| RGRRSRSASPRRSRS | 151 | Q16629 | |
| RSASPRRSRSISLRR | 156 | Q16629 | |
| ARVRRRGPRRSSSDI | 851 | P78364 | |
| SRSPRRRSRSPKRRS | 236 | Q8NAV1 | |
| YGRRRKKHRSRSRSR | 186 | Q01081 | |
| YGSRRKRSRSRSRGR | 76 | Q96IZ7 | |
| SKSRTRRSRSRPRLR | 101 | Q96IZ7 | |
| GDRKKRRTRSRSPER | 296 | O95218 | |
| SKRSRSRESSRPRGR | 626 | Q9NS56 | |
| SRESSRPRGRRDKKR | 631 | Q9NS56 | |
| RPRGRRDKKRSRTRD | 636 | Q9NS56 | |
| QRSASRDRRRRSKPL | 51 | P26368 | |
| RSQSSSRCRSRGRRK | 451 | Q15695 | |
| RSRRRRRSSRSRSKS | 1866 | P18583 | |
| RRSSRSRSKSRGRRS | 1871 | P18583 | |
| KTVRARSRTPSRRSR | 1916 | P18583 | |
| RRRRSRSVGRRRSFS | 1936 | P18583 | |
| RSRTPSRRSRTPSRR | 1956 | P18583 | |
| RRSRTPSRRSRTPSR | 1976 | P18583 | |
| RTPSRRSRTPSRRRR | 1986 | P18583 | |
| RSRTPSRRRRSRSVV | 1991 | P18583 | |
| RTPLRRRFSRSPIRR | 2021 | P18583 | |
| RRFSRSPIRRKRSRS | 2026 | P18583 | |
| SPIRRKRSRSSERGR | 2031 | P18583 | |
| APRARRLRLSASRRA | 231 | C9JLR9 | |
| KSGRRRRERRSTVLG | 151 | Q9P206 | |
| RERRRPREKRRSTGV | 841 | O14974 |